Stockholm (HedgeNordic) – Teresa Isele has embarked on her role as CEO of Rhenman & Partners Asset Management as of this week. Healthcare-focused asset manager Rhenman & Partners announced the appointment of Isele in late 2022 as a replacement for co-founder and now-former CEO Göran Nordström, who retired at the age of 69.
“We are thrilled to welcome Teresa Isele (pictured left) as our new CEO on her first day,” the team at Rhenman & Partners announces on LinkedIn. “Teresa will focus on the company’s development both in Sweden and internationally, working closely with the board and all employees in Rhenman & Partners’ Stockholm office.”
“We are thrilled to welcome Teresa Isele as our new CEO on her first day.”
Most recently, Isele served as the CEO of SwedSec, which provides a licensing system for employees within the Swedish financial services industry. Before SwedSec, she spent about six years at AP1, Första AP-fonden, in various roles including Chief Administrative Officer, acting CEO, general counsel and head of compliance. She also served as a lawyer at EQT for four years and law firm Vinge for an additional two years.
Rhenman & Partners has been running a healthcare-focused long-bised equity hedge fund, Rhenman Healthcare Equity L/S, since mid-2009. The fund’s main share class (IC1 EUR) has generated an annualized return of 16.4 percent since June 2009. “Rhenman & Partners is well equipped for the future despite a challenging macro environment,” Teresa Isele said in October last year in a press release announcing her appointment as CEO. “I look forward to continuing the development of the business together with the highly competent employees.”
